Dysbindin-1 gene contributes differentially to early- and adult-onset forms of functional psychosis

American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics

Volumn 156, Issue 3, 2011, Pages 322-333

  Fatjó Vilas, Mar ^a   Papiol, Sergi ^a,b   Estrada, Gemma ^a   Bombín, Igor ^c,d   Peralta, Victor ^e   Rosa, Araceli ^a   Parellada, Mara ^f   Miret, Salvador ^g   Martín, María ^h   Lázaro, Luisa ^a,i,j   Campanera, Sílvia ^g   Muñoz, Ma José ^h   Lera Miguel, Sara ⁱ   Arias, Bárbara ^a   Navarro, Ma Eulalia ^h   Castro Fornieles, Josefina ^a,i,j   Cuesta, Manuel J ^e   Arango, Celso ^f   Fañanás, Lourdes ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b MAX PLANCK INSTITUTE OF EXPERIMENTAL MEDICINE   (Germany)

^c Centro de Rehabilitación Neurológica   (Spain)

^d UNIVERSITY OF OVIEDO   (Spain)

^e Instituto de Investigación Sanitaria de Navarra   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^g Hospital Santa Maria   (Spain)

^h Area d'Adolescents Complex Assistencial en Salut Mental   (Spain)

ⁱ HOSPITAL CLÍNIC   (Spain)

^j INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

more..

Author keywords

Age at onset; Dysbindin 1 gene (DTNBP1); Estimated intelligence quotient; Executive functions; Family study; Functional psychosis

Indexed keywords

DYSBINDIN;

ADULT; ADULT ONSET AGE; ARTICLE; COGNITION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EARLY ONSET AGE; EXECUTIVE FUNCTION; EXON; FEMALE; FUNCTIONAL PSYCHOSIS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTELLIGENCE QUOTIENT; INTRON; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPE; PRIORITY JOURNAL; PSYCHOSIS; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE OF ONSET; CARRIER PROTEINS; CHILD; CHROMOSOMES, HUMAN, PAIR 6; COGNITION; EXONS; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; SIBLINGS;

EID: 79952606437     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/ajmg.b.31166     Document Type: Article

References (78)

1. Abecasis GR, Cardon LR, Cookson WO. 2000. A general test of association for quantitative traits in nuclear families. Am J Hum Genet 66(1): 279-292.
2. Andreasen NC, Flaum M, Arndt S. 1992. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Arch Gen Psychiatry 49(8): 615-623.
3. Barrett JC, Fry B, Maller J, Daly MJ. 2005. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21(2): 263-265.
4. Bellivier F, Golmard JL, Henry C, Leboyer M, Schurhoff F. 2001. Admixture analysis of age at onset in bipolar I affective disorder. Arch Gen Psychiatry 58(5): 510-512.
5. Benson MA, Newey SE, Martin-Rendon E, Hawkes R, Blake DJ. 2001. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain. J Biol Chem 276(26): 24232-24241.
6. Bora E, Yucel M, Pantelis C. 2009. Cognitive endophenotypes of bipolar disorder: A meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives. J Affect Disord 113(1-2): 1-20.
7. Bora E, Yucel M, Pantelis C. 2010. Cognitive impairment in schizophrenia and affective psychoses: Implications for DSM-V criteria and beyond. Schizophr Bull 36(1): 36-42.
8. Bray NJ, Buckland PR, Owen MJ, O'Donovan MC. 2003. Cis-acting variation in the expression of a high proportion of genes in human brain. Hum Genet 113(2): 149-153.
9. Bray NJ, Preece A, Williams NM, Moskvina V, Buckland PR, Owen MJ, O'Donovan MC. 2005. Haplotypes at the dystrobrevin binding protein 1 (DTNBP1) gene locus mediate risk for schizophrenia through reduced DTNBP1 expression. Hum Mol Genet 14(14): 1947-1954.
10. Bray NJ, Holmans PA, van den Bree MB, Jones L, Elliston LA, Hughes G, Richards AL, et al. 2008. Cis- and trans-loci influence expression of the schizophrenia susceptibility gene DTNBP1. Hum Mol Genet 17(8): 1169-1174.
11. Breen G, Prata D, Osborne S, Munro J, Sinclair M, Li T, Staddon S, et al. 2006. Association of the dysbindin gene with bipolar affective disorder. Am J Psychiatry 163(9): 1636-1638.
12. Burdick KE, Lencz T, Funke B, Finn CT, Szeszko PR, Kane JM, Kucherlapati R, et al. 2006. Genetic variation in DTNBP1 influences general cognitive ability. Hum Mol Genet 15(10): 1563-1568.
13. Calafell F, Bertranpetit J. 1994. Principal component analysis of gene frequencies and the origin of Basques. Am J Phys Anthropol 93(2): 201-215.
14. Chen XW, Feng YQ, Hao CJ, Guo XL, He X, Zhou ZY, Guo N, et al. 2008. DTNBP1, a schizophrenia susceptibility gene, affects kinetics of transmitter release. J Cell Biol 181(5): 791-801.
15. Colantuoni C, Hyde TM, Mitkus S, Joseph A, Sartorius L, Aguirre C, Creswell J, et al. 2008. Age-related changes in the expression of schizophrenia susceptibility genes in the human prefrontal cortex. Brain Struct Funct 213(1-2): 255-271.
16. Cox ET, Brennaman LH, Gable KL, Hamer RM, Glantz LA, Lamantia AS, Lieberman JA, et al. 2009. Developmental regulation of neural cell adhesion molecule in human prefrontal cortex. Neuroscience 162(1): 96-105.
17. Craddock N, O'Donovan MC, Owen MJ. 2006. Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull 32(1): 9-16.
18. Craddock N, O'Donovan MC, Owen MJ. 2009. Psychosis genetics: Modeling the relationship between schizophrenia, bipolar disorder, and mixed (or "schizoaffective") psychoses. Schizophr Bull 35(3): 482-490.
19. Datta SR, McQuillin A, Puri V, Choudhury K, Thirumalai S, Lawrence J, Pimm J, et al. 2007. Failure to confirm allelic and haplotypic association between markers at the chromosome 6p22.3 dystrobrevin-binding protein 1 (DTNBP1) locus and schizophrenia. Behav Brain Funct 3: 50.
20. Dean AG, Dean JA, Burton AH, Dicker RC. 1991. Epi Info: A general-purpose microcomputer program for public health information systems. Am J Prev Med 7(3): 178-182.
21. DeRosse P, Funke B, Burdick KE, Lencz T, Ekholm JM, Kane JM, Kucherlapati R, et al. 2006. Dysbindin genotype and negative symptoms in schizophrenia. Am J Psychiatry 163(3): 532-534.
22. Dickman DK, Davis GW. 2009. The schizophrenia susceptibility gene dysbindin controls synaptic homeostasis. Science 326(5956): 1127-1130.
23. Donohoe G, Frodl T, Morris D, Spoletini I, Cannon DM, Cherubini A, Caltagirone C, et al. 2009. Reduced occipital and prefrontal brain volumes in dysbindin-associated schizophrenia. Neuropsychopharmacology 35(2): 368-373.
24. Duan J, Martinez M, Sanders AR, Hou C, Burrell GJ, Krasner AJ, Schwartz DB, et al. 2007. DTNBP1 (Dystrobrevin binding protein 1) and schizophrenia: Association evidence in the 3' end of the gene. Hum Hered 64(2): 97-106.
25. Dudbridge F. 2003. Pedigree disequilibrium tests for multilocus haplotypes. Genet Epidemiol 25(2): 115-121.
26. Fallin MD, Lasseter VK, Avramopoulos D, Nicodemus KK, Wolyniec PS, McGrath JA, Steel G, et al. 2005. Bipolar I disorder and schizophrenia: A 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet 77(6): 918-936.
27. Fanous AH, Kendler KS. 2008. Genetics of clinical features and subtypes of schizophrenia: A review of the recent literature. Curr Psychiatry Rep 10(2): 164-170.
28. Frangou S, Hadjulis M, Vourdas A. 2008. The Maudsley early onset schizophrenia study: Cognitive function over a 4-year follow-up period. Schizophr Bull 34(1): 52-59.
29. Funke B, Finn CT, Plocik AM, Lake S, DeRosse P, Kane JM, Kucherlapati R, et al. 2004. Association of the DTNBP1 locus with schizophrenia in a U.S. population. Am J Hum Genet 75(5): 891-898.
30. Gauderman W, Morrison J. 2006. QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies.
31. Gaysina D, Cohen-Woods S, Chow PC, Martucci L, Schosser A, Ball HA, Tozzi F, et al. 2009. Association of the dystrobrevin binding protein 1 gene (DTNBP1) in a bipolar case-control study (BACCS). Am J Med Genet Part B 150B(6): 836-844.
32. Geller B, Williams M, Zimmerman B, Frazier J. 1996. Kiddie Shedule for Affective Disorders and Schizophrenia (WASH-U-KSADS). St Louis: Washington University.
33. Gornick MC, Addington AM, Sporn A, Gogtay N, Greenstein D, Lenane M, Gochman P, et al. 2005. Dysbindin (DTNBP1, 6p22.3) is associated with childhood-onset psychosis and endophenotypes measured by the Premorbid Adjustment Scale (PAS). J Autism Dev Disord 35(6): 831-838.
34. Guo AY, Sun J, Riley BP, Thiselton DL, Kendler KS, Zhao Z. 2009. The dystrobrevin-binding protein 1 gene: Features and networks. Mol Psychiatry 14(1): 18-29.
35. Hare E, Glahn DC, Dassori A, Raventos H, Nicolini H, Ontiveros A, Medina R, et al. 2010. Heritability of age of onset of psychosis in schizophrenia. Am J Med Genet Part B 153B(1): 298-302.
36. Heaton RK. 1981. Wisconsin Card Sorting Test: Computer Version-2. Research Edition. Odessa, FL: Psychological Assessment Resources, Inc.
37. Hollis C. 2000. Adolescent schizophrenia. Adv Psychiatr Treat 6: 83-92.
38. Jacobsen LK, Rapoport JL. 1998. Research update: Childhood-onset schizophrenia: Implications of clinical and neurobiological research. J Child Psychol Psychiatry 39(1): 101-113.
39. Joseph MF, Frazier TW, Youngstrom EA, Soares JC. 2008. A quantitative and qualitative review of neurocognitive performance in pediatric bipolar disorder. J Child Adolesc Psychopharmacol 18(6): 595-605.
40. Kumamoto N, Matsuzaki S, Inoue K, Hattori T, Shimizu S, Hashimoto R, Yamatodani A, et al. 2006. Hyperactivation of midbrain dopaminergic system in schizophrenia could be attributed to the down-regulation of dysbindin. Biochem Biophys Res Commun 345(2): 904-909.
41. Lezak M. 1995. Neuropsychological Assessment. New York, Oxford: Oxford University Press.
42. Li D, Collier DA, He L. 2006. Meta-analysis shows strong positive association of the neuregulin 1 (NRG1) gene with schizophrenia. Hum Mol Genet 15(12): 1995-2002.
43. Maher BS, Reimers MA, Riley BP, Kendler KS. 2010. Allelic heterogeneity in genetic association meta-analysis: An application to DTNBP1 and schizophrenia. Hum Hered 69(2): 71-79.
44. McClellan J, McCurry C. 1999. Early onset psychotic disorders: Diagnostic stability and clinical characteristics. Eur Child Adolesc Psychiatry 8(Suppl 1): I13-I19.
45. McGuffin P, Rijsdijk F, Andrew M, Sham P, Katz R, Cardno A. 2003. The heritability of bipolar affective disorder and the genetic relationship to unipolar depression. Arch Gen Psychiatry 60(5): 497-502.
46. Mutsuddi M, Morris DW, Waggoner SG, Daly MJ, Scolnick EM, Sklar P. 2006. Analysis of high-resolution HapMap of DTNBP1 (Dysbindin) suggests no consistency between reported common variant associations and schizophrenia. Am J Hum Genet 79(5): 903-909.
47. Narr KL, Szeszko PR, Lencz T, Woods RP, Hamilton LS, Phillips O, Robinson D, et al. 2009. DTNBP1 is associated with imaging phenotypes in schizophrenia. Hum Brain Mapp 30(11): 3783-3794.
48. Numakawa T, Yagasaki Y, Ishimoto T, Okada T, Suzuki T, Iwata N, Ozaki N, et al. 2004. Evidence of novel neuronal functions of dysbindin, a susceptibility gene for schizophrenia. Hum Mol Genet 13(21): 2699-2708.
49. Nyholt DR. 2004. A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74(4): 765-769.
50. Oyama S, Yamakawa H, Sasagawa N, Hosoi Y, Futai E, Ishiura S. 2009. Dysbindin-1, a schizophrenia-related protein, functionally interacts with the DNA-dependent protein kinase complex in an isoform-dependent manner. PLoS ONE 4(1): e4199.
51. Pavuluri MN, Birmaher B, Naylor MW. 2005. Pediatric bipolar disorder: A review of the past 10 years. J Am Acad Child Adolesc Psychiatry 44(9): 846-871.
52. Perkins DO, Leserman J, Jarskog LF, Graham K, Kazmer J, Lieberman JA. 2000. Characterizing and dating the onset of symptoms in psychotic illness: The Symptom Onset in Schizophrenia (SOS) inventory. Schizophr Res 44(1): 1-10.
53. Perlis RH, Miyahara S, Marangell LB, Wisniewski SR, Ostacher M, DelBello MP, Bowden CL, et al. 2004. Long-term implications of early onset in bipolar disorder: Data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder (STEP-BD). Biol Psychiatry 55(9): 875-881.
54. Posthuma D, Luciano M, Geus EJ, Wright MJ, Slagboom PE, Montgomery GW, Boomsma DI, et al. 2005. A genomewide scan for intelligence identifies quantitative trait loci on 2q and 6p. Am J Hum Genet 77(2): 318-326.
55. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, et al. 2007. PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81(3): 559-575.
56. Purcell SM, Wray NR, Stone JL, Visscher PM, O'Donovan MC, Sullivan PF, Sklar P. 2009. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460(7256): 748-752.
57. Rapoport JL, Addington A, Frangou S. 2005. The neurodevelopmental model of schizophrenia: What can very early onset cases tell us? Curr Psychiatry Rep 7(2): 81-82.
58. Reitan R, Wolfson D. 1985. The Halstead-Reitan Neuropsychological Test Battery. Tuscon, AZ: Neuropsychology Press.
59. Riley B, Kuo PH, Maher BS, Fanous AH, Sun J, Wormley B, O'Neill FA, et al. 2009. The dystrobrevin binding protein 1 (DTNBP1) gene is associated with schizophrenia in the Irish Case Control Study of Schizophrenia (ICCSS) sample. Schizophr Res 115(2-3): 245-253.
60. Rutter M, Kim-Cohen J, Maughan B. 2006. Continuities and discontinuities in psychopathology between childhood and adult life. J Child Psychol Psychiatry 47(3-4): 276-295.
61. Salvatore P, Baldessarini RJ, Tohen M, Khalsa HM, Sanchez-Toledo JP, Zarate CA Jr, Vieta E, et al. 2009. McLean-Harvard International First-Episode Project: Two-year stability of DSM-IV diagnoses in 500 first-episode psychotic disorder patients. J Clin Psychiatry 70(4): 458-466.
62. Sattler JM. 2001. Wechsler adult intelligence scale-III: description. In: Sattler JM, editor. Assessment of Children Cognitive Applications. 4th edition. San Diego: Jerome M. Sattler, Publisher, Inc.
63. Schwab SG, Albus M, Hallmayer J, Honig S, Borrmann M, Lichtermann D, Ebstein RP, et al. 1995. Evaluation of a susceptibility gene for schizophrenia on chromosome 6p by multipoint affected sib-pair linkage analysis. Nat Genet 11(3): 325-327.
64. Schwab SG, Knapp M, Mondabon S, Hallmayer J, Borrmann-Hassenbach M, Albus M, Lerer B, et al. 2003. Support for association of schizophrenia with genetic variation in the 6p22.3 gene, dysbindin, in sib-pair families with linkage and in an additional sample of triad families. Am J Hum Genet 72(1): 185-190.
65. Scourfield J, McGuffin P. 2001. Genetic aspects. In: Remschmidt H, editor. Schizophrenia in Children and Adolescents. Cambridge: Cambridge University Press. pp. 119-134.
66. Spreen O, Benton AL. 1965. Comparative studies of some psychological tests for cerebral damage. J Nerv Ment Dis 140: 323-333.
67. Straub RE, MacLean CJ, O'Neill FA, Burke J, Murphy B, Duke F, Shinkwin R, et al. 1995. A potential vulnerability locus for schizophrenia on chromosome 6p24-22: Evidence for genetic heterogeneity. Nat Genet 11(3): 287-293.
68. Straub RE, Jiang Y, MacLean CJ, Ma Y, Webb BT, Myakishev MV, Harris-Kerr C, et al. 2002. Genetic variation in the 6p22.3 gene DTNBP1, the human ortholog of the mouse dysbindin gene, is associated with schizophrenia. Am J Hum Genet 71(2): 337-348.
69. Sullivan PF, Kendler KS, Neale MC. 2003. Schizophrenia as a complex trait: Evidence from a meta-analysis of twin studies. Arch Gen Psychiatry 60(12): 1187-1192.
70. Tang J, Legros RP, Louneva N, Yeh L, Cohen JW, Hahn CG, Blake DJ, et al. 2009. Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression. Hum Mol Genet 18(20): 3851-3863.
71. Van Den Bogaert A, Schumacher J, Schulze TG, Otte AC, Ohlraun S, Kovalenko S, Becker T, et al. 2003. The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease. Am J Hum Genet 73(6): 1438-1443.
72. Vilella E, Costas J, Sanjuan J, Guitart M, De Diego Y, Carracedo A, Martorell L, et al. 2008. Association of schizophrenia with DTNBP1 but not with DAO, DAOA, NRG1 and RGS4 nor their genetic interaction. J Psychiatr Res 42(4): 278-288.
73. Wechsler D. 1997. Wechsler Adult Intelligence Scale, 3rd edition (WAIS-III). Administration and scoring manual. Psychological Corporation, San Antonio, USA: Adaptación Española: (1999) TEA ediciones, Madrid.
74. Wechsler D. 2004. WISC-IV integrated technical and interpretive manual. Administration and scoring manual, Spanish adaptation. Madrid: TEA Ediciones.
75. Weickert CS, Straub RE, McClintock BW, Matsumoto M, Hashimoto R, Hyde TM, Herman MM, et al. 2004. Human dysbindin (DTNBP1) gene expression in normal brain and in schizophrenic prefrontal cortex and midbrain. Arch Gen Psychiatry 61(6): 544-555.
76. Weickert CS, Rothmond DA, Hyde TM, Kleinman JE, Straub RE. 2008. Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients. Schizophr Res 98(1-3): 105-110.
77. Wessman J, Paunio T, Tuulio-Henriksson A, Koivisto M, Partonen T, Suvisaari J, Turunen JA, et al. 2009. Mixture model clustering of phenotype features reveals evidence for association of DTNBP1 to a specific subtype of schizophrenia. Biol Psychiatry 66(11): 990-996.
78. Zinkstok JR, de Wilde O, van Amelsvoort TA, Tanck MW, Baas F, Linszen DH. 2007. Association between the DTNBP1 gene and intelligence: A case-control study in young patients with schizophrenia and related disorders and unaffected siblings. Behav Brain Funct 3: 19.